Robert L. Scavo Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 months ago
Robert L. Scavo has an estimated net worth of at least $13.5 million*, as of Oct. 29, 2025. They own 503,014 shares of ALHC stock. They have sold 284,427 shares of ALHC stock since 2021, for an estimated $3.2 million.
Robert L. Scavo $ALHC SEC Form 4 Insider Trading
Robert L. Scavo has filed a total of 16 insider trades in $ALHC since 2021. Their most recent trade was a sale of 3,813 shares, made on Dec 29, 2025. Their largest trade was a sale of 65,728 shares, made on Dec 29, 2025. We estimate that they now own 503,014 shares of $ALHC, worth an estimated $10.3 million.
Insider Trading at $ALHC
There have been a total of 327 insider trades reported at $ALHC since 2021, with 203,000 shares purchased and 151.1 million shares sold. The most active insider traders in $ALHC stock have been John E Kao, Robert Thomas Freeman, and Dawn Christine Maroney. The most recent trade was a sale of 3,813 shares reported by Robert L. Scavo (Chief Information Officer), made on Dec 29, 2025.
History of Insider Stock Trades by Robert L. Scavo
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
ALHC
|
Sale | 3,813 | Dec 29, 2025 | Dec. 30, 2025, 6:01 p.m. |
|
ALHC
|
Sale | 65,728 | Dec 29, 2025 | Dec. 30, 2025, 6:01 p.m. |
|
ALHC
|
Sale | 8,412 | Sep 10, 2025 | Sept. 10, 2025, 8:08 p.m. |
|
ALHC
|
Sale | 21,123 | Sep 10, 2025 | Sept. 10, 2025, 8:08 p.m. |
|
ALHC
|
Sale | 60,000 | Jun 10, 2025 | June 12, 2025, 5:47 p.m. |
|
ALHC
|
Sale | 40,863 | Jun 11, 2025 | June 12, 2025, 5:47 p.m. |
|
ALHC
|
Sale | 2,864 | Mar 27, 2025 | March 28, 2025, 8:30 p.m. |
|
ALHC
|
Sale | 4,634 | Mar 19, 2025 | March 19, 2025, 9:54 p.m. |
|
ALHC
|
Sale | 2,600 | Mar 19, 2025 | March 19, 2025, 9:54 p.m. |
|
ALHC
|
Sale | 3,923 | Mar 18, 2025 | March 19, 2025, 9:54 p.m. |
|
ALHC
|
Sale | 5,238 | Mar 12, 2025 | March 13, 2025, 5:07 p.m. |
|
ALHC
|
Sale | 75 | Mar 12, 2025 | March 13, 2025, 5:07 p.m. |
|
ALHC
|
Sale | 55,403 | Mar 06, 2025 | March 6, 2025, 8:35 p.m. |
|
ALHC
|
Sale | 1,821 | Mar 28, 2024 | March 29, 2024, 8 p.m. |
|
ALHC
|
Sale | 3,078 | Mar 19, 2024 | March 21, 2024, 5 p.m. |
|
ALHC
|
Sale | 4,852 | Mar 15, 2024 | March 15, 2024, 8 p.m. |
$ALHC Executives and Stock Owners with Insider Trades
-
John E Kao, Chief Executive Officer
-
Robert Thomas Freeman, Chief Financial Officer
-
Dawn Christine Maroney, President, Markets
-
Christopher J Joyce, Chief Legal and Admin. Officer
-
Dawn Christine Maroney, President
-
Dinesh M. Kumar, Chief Med & Operating Officer
-
Hakan Kardes, Chief Experience Officer
-
Hyong Kim, Chief Medical Officer
-
Robert L. Scavo, Chief Information Officer
-
Andreas P. Wagner, Chief Human Resources Officer
-
Dinesh M. Kumar, Chief Medical Officer
-
Joseph S Konowiecki, Chairman of the Board
-
Sebastian Burzacchi, COO - Mgmt Services Org
-
Richard A. Cross, SVP, General Counsel
-
Donald Steven Furman, Chief Clinical Officer
-
Rajesh Shrestha, Pres., New Markets & CBO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.